How you can improve the efficiency of your chromatographic workflow more
To use all functions of this page, please activate cookies in your browser.
Filling capsules is a very common activity in clinical first-in-man studies, but exactly how this is carried out typically depends on the throughput required and the resources available.
For early clinical trials (phase 0 and 1) the objective is to evaluate a drug’s delivery method and dosage regimen, and studies typically last up to one year. Trials are usually managed internally by the pharmaceutical company’s toxicology department or outsourced to specialist contract research organizations (CRO’s), such as CoreRx, Inc.
Depending on the nature of the drug and test subject, new pharmaceuticals are often administered via gelatine capsules. Filling capsules is often carried out manually, either because sample series are too small for filling machines or because different amounts are required per capsule, which is not easy to automate. This necessitates manually weighing highly potent, hazardous substances precisely with a spatula, which is tricky and challenging. As the materials used in clinical studies are usually of unknown potency, any spillage or exposure presents a safety risk to the scientist.
First-in-man trials are strictly regulated by the United States Food and Drug Administration (FDA) and require capsules for phase 0 and 1 trials to be filled under sterile conditions. Therefore, any substances that come into contact with the drug must be sterile and made of an FDA-compliant material. Good Laboratory Practice (GLP) must also be applied which demands reproducibility, traceability, and full documentation.
CoreRx, Inc., a contract research organization (CRO) based in Florida, work predominantly on formulation development and analytical development projects for clients in the pharmaceutical industry. They frequently encounter similar challenges in the various development programs they undertake:
Here is an example of a dose range finding study, undertaken for a client manufacturing Phase I clinical trial material. The study required the manufacture of four batches of different dosage strengths – 0.3, 1, 3, and 9 mg – at approximately 1,000 capsules each. This project faced all the challenges described above: very tight timescales; clinical time already scheduled; synthesis issues at the manufacturer and therefore a limited amount of material available. In addition, containment was a major concern. The substance was not cytotoxic, but had a very severe physiological effect at very low doses. The compound was being developed for irritable bowel syndrome (IBS) with constipation and thus had a very strong laxative effect. The API itself had extremely undesirable physical characteristics for ease of dosing. It was an amorphous, filamentous material, which looked like cotton candy in a jar – very fibrous and with absolutely no flow. It had a bulk density of 0.04 gram per milliliter (g/mL). Using Quantos with a manual sample changer, size 0 HPMC capsules were prepared for the four fill strengths. The 1 mg, 3 mg and 9 mg strengths were weighed as neat API in capsule, but the 0.3 mg strength had to be achieved as a blend, because 0.3 mg was too low to accurately weigh on the Quantos balance. Several different diluents were evaluated before selecting mannitol, and the 0.3 mg strength was prepared as a blend of API in mannitol (1.71 %).
Table 1 shows how precise and accurate the average fill rates were for these capsule batches prepared using the Quantos system. Reject rates were low – down to 0.5 % and RSD’s were good, particularly for the higher fill weights (10 – 20 mg targets). Note: The API strengths prepared include a correction factor which equates to 1.14 mg per milligram of active compound. Additional analysis of the 0.3 mg strength capsules containing the API / mannitol blend showed that the capsules were within specifications for content uniformity and no segregation was observed.
Quantos, as a validated filling system, offered reduced labor time compared to manual filling in a Good Manufacturing Practice (GMP) regulated setting. A technician is capable of preparing 85 – 125 capsules per day manually in the lab filling 3 mg target weights (technician dependent). This compares to 60 capsules per hour using the system. The manual estimation is influenced by the specific standard operating procedure (SOP), but a manual fill in the GMP area requires the eyes of two technicians (second person verification). For this reason, it becomes very labor-intensive to put enough people into a room to fill capsules manually, whilst conforming to the SOP’s, at a comparable rate to Quantos. The benefit of using a validated filling system is that only one operator is required to carry out the task.
Reduced cleaning requirements are another important benefit. In setting up a typical encapsulation machine, there are a number of product contact parts that have to be cleaned and verified, swabbed after dosing to show residual API left on the instrument. Quantos, with its self-contained dosing head, minimizes risk of spillage. The only potential product contact part is the sample changer. Even though all the material is dosed into the capsule shell and no spillage is observed on the carousel, the Ergodisc still must be washed and swabbed as it is in contact with the capsule shell. However, this is straightforward because it involves only one easily detachable piece requiring verification.
For projects involving cytotoxic or potent materials, Quantos offers a significant safety benefit. This system provides a good level of containment and reduces the potential exposure of the operators. This is due to the mode of operation of the dosing head, the precision with which it can dispense into capsules, and the fact that it is a self-contained unit. The drug substance can be stored in a standard jar or vial with the dosing head screwed on top. The whole vessel with dispensing head can be stored in the refrigerator if necessary. If the drug product is moisture-sensitive or oxygen-sensitive, this concept reduces the exposure of the substance to the ambient environment. It also minimizes any substance loss due to transfer from one storage or dispensing vessel to another. The design of the dosing head design offers flexibility for dispensing material with various characteristics.
Reduced waste or spillage is another benefit of using the Quantos system. If anyone has weighed manually with a spatula, especially very small quantities such as 1 – 5 mg, they will know that the amount lost or spilled can be significant. At this phase, when working with new chemical entities that can cost thousands of dollars per gram, it is important to avoid wasting any.
CoreRx chose to implement the Quantos powder dosing system (from Mettler Toledo) to address their capsule filling challenges. Since 2009, they have been filling capsules (and vials) using a Quantos solution with a manual sample changer (Ergodisc). With its great flexibility, the system neatly bridges the gap between manual capsule filling and costly high-throughput filling machines and offers a significant and economical means of preparing early-phase clinical trial materials.
How you can improve the efficiency of your chromatographic workflow more
The innovative new weighing pan makes it possible to deliver results up to twice as fast, even under harsh conditions. more
Outstanding weighing performance ✓ Audit-proof results every time ✓ Unique aerodynamic weighing pan ✓ more
Consistently reliable results ✓ Versatile connectivity for data transfer ✓ 11 built-in weighing applications ✓ more
The ideal equipment for all methods ✓ Easy set up and operation ✓ Convenient user guidance ✓ more
METTLER TOLEDO has launched its new Dubai Free Zone Competence Center. This new facility will offer advanced analytical support for all industries operating in the Middle East and North Africa. It will also provide hands-on equipment training for METTLER TOLEDO’s range of products, which ar ... more
Mettler Toledo presents a special offer for 2016 - a limited-edition, full-color lab calendar. More than a way to track days and dates, this 12-month calendar will provide a series of enlightening topics devoted to ensuring weighing accuracy in all critical lab processes. Using calendar pag ... more
The English version of the q&more online portal is now available online. The q&more portal was developed in a unique cooperation between succidia AG and CHEMIE.DE Information Service GmbH, and is supported by METTLER TOLEDO. It is aimed specifically at decision-makers, and uses attractive c ... more
Weighing is one of the key activities carried out in every quality control (QC) laboratory. Usually it is one of the first steps in a whole analysis chain, e.g. when a sample or a standard is prepared for subsequent dilution and HPLC or qNMR analysis. more
Metrological traceability is necessary for consistent, comparable and valid measurement values. As a fundamental concept of modern-day metrology, it allows measurement results to be internationally recognized and is required by norms and accreditation standards all over the world. The trace ... more
Lean management has expanded in scope to establish itself in corporate functions beyond production. In present-day laboratory operations, it forms a basis for optimized processes and efficient quality management, providing valuable tools for the digital transition to Laboratory 4.0. more
Igor Knapp, born in 1968, is a qualified computer science engineer and Team Leader for Interaction Design at Mettler-Toledo GmbH. In 1993, he successfully completed a design education at the Basel School of Design (Switzerland) and subsequently worked for more than seven years in corporate ... more
Christoph Jansen, born in 1962, studied chemistry at the University of Cologne and received his doctorate there from D.O. Hummel in instrumental analytics. He was a founding member of the association “Angewandte Spektrometrie Köln e.V.” (Applied Spectrometry, Cologne) and worked as an appli ... more
Daniel Fuchs, born in 1969, studied Services Marketing and Management (MAS SMM) at the University of Lucerne and holds degrees in Product and Service Marketing of the Swiss Federal government. At the Zurich University of Applied Sciences he gained the certification of Lean Manager Service f ... more
Matthew Greene is a senior formulation scientist at CoreRx, Inc. in Tampa, Florida. He is also Assistant Professor of the College of Pharmacy at the University of South Florida. Matthew has 12 years’ experience in pharmaceutical product development and has worked on the development of a wid ... more
The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.
> more about q&more
q&more is supported by: